Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). NGL Fine-Chem's share price for the quarter that ended in Mar. 2026 was ₹2057.1. NGL Fine-Chem's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 6 Mil. Therefore, NGL Fine-Chem's market cap for the quarter that ended in Mar. 2026 was ₹12,709 Mil.
NGL Fine-Chem's quarterly market cap
increased
from Sep. 2025 (₹8,683 Mil) to Dec. 2025 (₹8,688 Mil) and
increased
from Dec. 2025 (₹8,688 Mil) to Mar. 2026 (₹12,709 Mil).
NGL Fine-Chem's annual market cap
declined
from Mar. 2024 (₹12,937 Mil) to Mar. 2025 (₹7,000 Mil) but then
increased
from Mar. 2025 (₹7,000 Mil) to Mar. 2026 (₹12,709 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. NGL Fine-Chem's Enterprise Value for Today is ₹19,763 Mil.
NGL Fine-Chem (NSE:NGLFINE) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
NGL Fine-Chem Market Cap Related Terms
NGL Fine-Chem Market Cap Historical Data
* Premium members only.
The historical data trend for NGL Fine-Chem's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NGLFINE vs LLY, JNJ, ABBV: Market Cap Comparison
For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NGL Fine-Chem Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Market Cap distribution charts can be found below:
* The bar in red indicates where NGL Fine-Chem's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
NGL Fine-Chem's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGL Fine-Chem (NSE:NGLFINE) has a Market Cap of ₹19,138 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NGL Fine-Chem and its competitors. According to the industry distribution chart, NGL Fine-Chem ranks #518 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 50.7%.
Is NGL Fine-Chem's Market Cap too high?
NGL Fine-Chem's current Market Cap is ₹19,138 Mil. Based on the distribution chart, NGL Fine-Chem ranks #518 out of 1022 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, NGL Fine-Chem has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NGL Fine-Chem's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, NGL Fine-Chem ranks #518 out of 1022 companies for Market Cap. This places NGL Fine-Chem in the lower half of its industry. The industry median Market Cap is 210.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 210.16, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NGL Fine-Chem and its competitors. For the Drug Manufacturers industry, the median Market Cap is 210.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NGL Fine-Chem's current Market Cap is ₹19,138 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NGL Fine-Chem stock overvalued right now?
Based on GuruFocus' analysis, NGL Fine-Chem (NSE:NGLFINE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,811.32, compared to a current price of ₹3,107.50 — trading 10.5% above its estimated fair value. The current Market Cap is ₹19,138 Mil. NGL Fine-Chem's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For NGL Fine-Chem (NSE:NGLFINE), the current Market Cap is ₹19,138 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NGL Fine-Chem (NSE:NGLFINE) Overvalued in 2026?
Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be overvalued.
The current stock price of ₹3,107.50 is trading 10.5% above its estimated GF Value™ of ₹2,811.32.
GuruFocus considers NGL Fine-Chem to be Modestly Overvalued.
Key valuation signals for NSE:NGLFINE:
Market Cap: ₹19,138 Mil
GF Value™: ₹2,811.32 vs. price of ₹3,107.50 (10.5% above fair value)
No single metric tells the full story. See the NSE:NGLFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
78GF Score
Get the complete analysis for NSE:NGLFINE
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NGLFINE has been successfully added to your 
